journal article·2026-04Open access

Acidic phosphate microenvironment within calcium phosphate bone graft substitutes drives ectopic bone formation in mice

Y. Maazouz, F. El Harouni, J. Piot, N. Warfing, R. De Miguel, N. Döbelin, M. Bohner

Abstract

Material-induced heterotopic ossification (MIHO) by calcium-phosphate (CaP) bone graft substitutes (BGS) is difficult to anticipate because pore architecture, surface microstructure, and interfacial chemistry are often altered simultaneously. We compared six CaP granule formulations using an in-depth physical and chemical characterization. This included properties like granule size, pore architecture, intragranular concavities, specific surface area and microporosity, phase analysis, and controlled solution exposures that emulate confined fluid in pores to quantify pH, phosphate, calcium, and Ca/P release. These in-vitro readouts were paired with an intramuscular mouse model assessed at 35 and 56 days (early/late ossification centers, spicule density, bone area fraction, and standard host-reaction scores). Rank-based statistics mapped predictors to outcomes. Across materials, MIHO was observed primarily when two domains aligned. Physically, curvature-rich intragranular macropores were positively associated with the initiation of ectopic bone, while micro/nano-textured surface area within those pores was associated with later consolidation. Chemically, the most MIHO-competent materials tended to exhibit a phosphate-rich, mildly acidic interfacial milieu under confined-liquid conditions; this signature—captured by increased phosphate, decreased pH, and a reduced Ca/P release ratio—showed the strongest correlations with late histomorphometric endpoints. Apparent “phase effects” may largely reflect the interfacial chemistry those phases produced rather than intrinsic rankings based on solubility. The data suggest a simple, actionable rule set: concave, well-interconnected pores and micro/nano texture may help localize and sustain an acidic phosphate microenvironment that may bias soft tissues toward ectopic ossification. Practically, measuring ΔpH, ΔPO 4 , and Ca/P under confined-liquid conditions may provide candidate in-vitro surrogates for MIHO and a rational basis to design CaP grafts either to promote osteoinduction where desired or to avoid it where it is a risk.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Heterotopic Ossification and Related Conditions · Cervical and Thoracic Myelopathy · Alkaline Phosphatase Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (78)

Show source-provided references
1. Notes on the later stages of the repair of kidney tissue (dog) with special reference to pro-liferation of the pelvic epithelium and hetero-plastic bone formation
2. Calcium deposits and new bone formation in muscle in rabbits10.1016/S0022-4804(61)80010-3 ↗
3. The bone induction principle10.1097/00003086-196707000-00026 ↗
4. Inductive substrates for bone formation10.1097/00003086-196807000-00005 ↗
5. Bone: formation by autoinduction10.1126/science.150.3698.893 ↗
6. Osteogenesis in the interior of intramuscular implants of decalcified bone matrix10.1097/00003086-196500430-00026 ↗
7. The accessibility of the bone induction principle in surface-decalcified bone implants
8. Bone morphogenetic protein10.1177/00220345710500060601 ↗
9. The experimental production of ectopic cartilage and bone in the10.2106/00004623-194931040-00007 ↗
10. Bone and cartilage induction in the rabbit
11. Plasmin prevents dystrophic calcification after muscle injury10.1002/jbmr.2973 ↗
12. Trauma-induced nanohydroxyapatite deposition in skeletal muscle is sufficient to drive heterotopic ossification10.1007/s00223-018-0502-5 ↗
13. Heterotopic ossification: a comprehensive review10.1002/jbm4.10172 ↗
14. Bone induction in implants of decalcified bone and dentine
15. Heterotopic bone formed in a synthetic sponge in the skin of young pigs10.1038/223088a0 ↗
16. Biochemical differences between dystrophic calcification of cross-linked collagen implants and mineralization during bone induction, Calcif10.1007/BF02556366 ↗
17. Osteoinduction of porous bioactive titanium metal10.1016/S0142-9612(03)00551-9 ↗
18. Heterotopic bone formation by nano-apatite containing poly(D,Llactide) composites10.22203/eCM.v019a24 ↗
19. Comparative in vivo study of six hydroxyapatite-based bone graft substitutes10.1002/jor.20648 ↗
20. 3D microenvironment as essential element for osteoinduction by biomaterials10.1016/j.biomaterials.2004.09.056 ↗
21. Variation of the bone forming ability with the physicochemical properties of calcium phosphate bone substitutes10.1039/C7BM00717E ↗
22. Osteoinductive biomaterials: current knowledge of properties, experimental models and biological mechanisms10.22203/eCM.v021a31 ↗
23. A proposed mechanism for material-induced heterotopic ossification10.1016/j.mattod.2018.10.036 ↗
24. Corrigendum to ‘In vitro measurement of the chemical changes occurring within β-tricalcium phosphate bone graft substitutes’10.1016/j.actbio.2019.11.035 ↗
25. Cell-free, quantitative mineralization measurements as a proxy to identify osteoinductive bone graft substitutes10.1016/j.biomaterials.2021.120912 ↗
26. Sustained local ionic homeostatic imbalance caused by calcification modulates inflammation to trigger heterotopic ossification10.1016/j.actbio.2022.03.057 ↗
27. Ion reactivity of calcium-deficient hydroxyapatite in standard cell culture media10.1016/j.actbio.2011.07.016 ↗
28. Biomimetic versus sintered calcium phosphates: the In vitro behavior of osteoblasts and mesenchymal stem cells10.1089/ten.tea.2016.0406 ↗
29. In vitro response of mesenchymal stem cells to biomimetic hydroxyapatite substrates: a new strategy to assess the effect of ion exchange10.1016/j.actbio.2018.06.025 ↗
30. In vitro measurement of the chemical changes occurring within β-tricalcium phosphate bone graft substitutes10.1016/j.actbio.2019.11.035 ↗
31. Osteogenesis in extraskeletally implanted porous calcium phosphate ceramics: variability among different kinds of animals10.1016/0142-9612(96)00044-0 ↗
32. Cross-Species comparison of ectopic bone Formation10.1089/ten.2006.12.1607 ↗
33. Osteogenicity of biphasic calcium phosphate ceramics and bone autograft in a goat model10.1016/j.biomaterials.2007.11.034 ↗
34. Performance of osteoinductive biphasic calcium-phosphate ceramic in a critical-sized defect in goats10.4028/www.scientific.net/KEM.309-311.1303 ↗
35. The influence of genetic factors on the osteoinductive potential of calcium phosphate ceramics in mice10.1016/j.biomaterials.2012.04.021 ↗
36. ASTM F2529 − 13. Standard Guide for in Vivo Evaluation of Osteoinductive Potential for Materials Containing Demineralized Bone (DBM)1, (n.d.).
37. Profex: a graphical user interface for the Rietveld refinement program BGMN10.1107/S1600576715014685 ↗
38. Significant precision in crystal structure details: holly springs hydroxyapatite10.1107/S0567740869004298 ↗
39. Crystallographic studies of the role of Mg as a stabilizing impurity in β-Ca3(PO4)2. II. Refinement of Mg-containing β-Ca3(PO4)210.1016/0022-4596(77)90002-0 ↗
40. The crystal structure of α-Ca3(PO4)210.1107/S0567740877006037 ↗
41. In vitro measurement of the chemical changes occurring within β-tricalcium phosphate bone graft substitutes10.1016/j.actbio.2019.11.035 ↗
42. 2012
43. Can bioactivity be tested in vitro with SBF solution?10.1016/j.biomaterials.2009.01.008 ↗
44. The material and biological characteristics of osteoinductive calcium phosphate ceramics10.1093/rb/rbx024 ↗
45. Osteoinduction by foamed and 3D-Printed calcium phosphate scaffolds: effect of nanostructure and pore Architecture10.1021/acsami.7b14175 ↗
46. Mineralization in micropores of calcium phosphate scaffolds10.1016/j.actbio.2018.11.003 ↗
47. Submicron-scale surface architecture of tricalcium phosphate directs osteogenesis in vitro and in vivo10.22203/eCM.v027a20 ↗
48. Influence of surface microstructure and chemistry on osteoinduction and osteoclastogenesis by biphasic calcium phosphate discs10.22203/eCM.v029a24 ↗
49. Accelerated bone formation by biphasic calcium phosphate with a novel sub-micron surface topography10.22203/eCM.v037a05 ↗
50. Correlations between macrophage polarization and osteoinduction of porous calcium phosphate ceramics10.1016/j.actbio.2019.12.019 ↗
51. Liposomal clodronate inhibition of osteoclastogenesis and osteoinduction by submicrostructured beta-tricalcium phosphate10.1016/j.biomaterials.2014.03.013 ↗
52. Osteoclast resorption of beta-tricalcium phosphate controlled by surface architecture10.1016/j.biomaterials.2014.05.048 ↗
53. Macrophage polarization plays roles in bone formation instructed by calcium phosphate ceramics10.1039/C9TB02932J ↗
54. 3D microenvironment as essential element for osteoinduction by biomaterials10.1016/j.biomaterials.2004.09.056 ↗
55. Impact of biomimicry in the design of osteoinductive bone substitutes: nanoscale matters10.1021/acsami.8b20749 ↗
56. Macropore regulation of hydroxyapatite osteoinduction via microfluidic Pathway10.3390/ijms231911459 ↗
57. 3D printing calcium phosphate ceramics with high osteoinductivity through pore architecture optimization10.1016/j.actbio.2024.07.008 ↗
58. Substrate geometry directs the in vitro mineralization of calcium phosphate ceramics10.1016/j.actbio.2013.10.026 ↗
59. Assessment of protein entrapment in hydroxyapatite scaffolds by size exclusion chromatography10.1007/s13758-012-0037-7 ↗
60. Calcium phosphate-based osteoinductive materials10.1021/cr800427g ↗
61. Osteoinduction by biomaterials–physicochemical and structural influences10.1002/jbm.a.30712 ↗
62. Osteoinductive ceramics as a synthetic alternative to autologous bone grafting10.1073/pnas.1003600107 ↗
63. A comparison of bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) implanted in muscle and bone of dogs at different time periods10.1002/jbm.a.30707 ↗
64. Material-dependent bone induction by calcium phosphate ceramics: a 2.5-year study in dog10.1016/S0142-9612(00)00450-6 ↗
65. Effect of nano-structural properties of biomimetic hydroxyapatite on osteoimmunomodulation10.1016/j.biomaterials.2018.07.058 ↗
66. Nanocrystalline apatites: the fundamental role of water10.2138/am-2018-6415 ↗
67. Surface characteristics of nanocrystalline apatites: effect of Mg surface enrichment on morphology, surface hydration species, and cationic environments10.1021/la804230j ↗
68. Surface properties of biomimetic nanocrystalline apatites; applications in biomaterials10.1016/j.pcrysgrow.2014.09.005 ↗
69. Acidosis inhibits bone Formation by osteoblasts in vitro by preventing mineralization, calcif10.1007/s00223-004-0285-8 ↗
70. Osteoblast-like cellular response to dynamic changes in the ionic extracellular environment produced by calcium-deficient hydroxyapatite10.1007/s10856-012-4705-4 ↗
71. Calcium-to-phosphorus releasing ratio affects osteoinductivity and osteoconductivity of calcium phosphate bioceramics in bone tissue engineering10.1186/s12938-023-01067-1 ↗
72. The osteoinductivity of calcium phosphate-based biomaterials: a tight interaction with bone healing
73. Biomaterials in heterotopic ossification: prophylaxis and promotion10.1016/j.cej.2024.153811 ↗
74. The roles of acidosis in osteoclast biology10.3389/fphys.2016.00222 ↗
75. Acidosis environment promotes osteoclast formation by acting on the last phase of preosteoclast differentiation: a study to elucidate the action points of acidosis and search for putative target molecules10.1016/j.ejphar.2011.04.062 ↗
76. Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro
77. Osteoinduction with highly purified β-tricalcium phosphate in dog dorsal muscles and the proliferation of osteoclasts before heterotopic bone formation10.1016/j.biomaterials.2006.04.016 ↗
78. EP4 agonist accelerates osteoinduction and degradation of P-tricalcium phosphate by stimulating osteoclastogenesis10.1002/jbm.a.31984 ↗